188 related articles for article (PubMed ID: 6606651)
1. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
[TBL] [Abstract][Full Text] [Related]
2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
4. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
5. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes.
Fossati G; Taramelli D; Balsari A; Bogdanovich G; Andreola S; Parmiani G
Int J Cancer; 1984 May; 33(5):591-7. PubMed ID: 6233227
[TBL] [Abstract][Full Text] [Related]
6. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
[TBL] [Abstract][Full Text] [Related]
8. Functional consequence of variation in melanoma antigen expression.
Zehngebot LM; Alexander MA; Guerry D; Cines DB; Mitchell K; Herlyn M
Cancer Immunol Immunother; 1983; 16(1):30-4. PubMed ID: 6605801
[TBL] [Abstract][Full Text] [Related]
9. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
[TBL] [Abstract][Full Text] [Related]
10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
12. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
[TBL] [Abstract][Full Text] [Related]
13. Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatment.
Liao SK; Kwong PC; Dent PB; Jerry LM
Tissue Antigens; 1982 Aug; 20(2):147-51. PubMed ID: 6958088
[TBL] [Abstract][Full Text] [Related]
14. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
15. Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.
Parmiani G; Fossati G; Taramelli D; Anichini A; Balsari A; Gambacorti-Passerini C; Sciorelli G; Cascinelli N
Cancer Metastasis Rev; 1985; 4(1):7-26. PubMed ID: 3888384
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.
Taramelli D; Fossati G; Balsari A; Marolda R; Parmiani G
Int J Cancer; 1984 Dec; 34(6):797-806. PubMed ID: 6334655
[TBL] [Abstract][Full Text] [Related]
17. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
18. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
Chu E; Umetsu D; Rosen F; Geha RS
J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
[TBL] [Abstract][Full Text] [Related]
20. Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines.
Pollack MS; Chin-Louie J; Moshief RD
Hum Immunol; 1984 Feb; 9(2):75-87. PubMed ID: 6607912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
